首页> 外文OA文献 >Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study

【2h】

Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study

机译：伊马替尼戒断综合征和较长的伊马替尼持续时间与治疗停止后的较低分子复发的密切关联：孩子研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
S.-E. Lee; S. Y. Choi; H.-Y. Song; S.-H. Kim; M.-Y. Choi; J. S. Park; H.-J. Kim; D. Y. Zang; S. Oh; H. Kim; Y. R. Do; J.-Y. Kwak; J.-A. Kim; D.-Y. Kim; Y.-C. Mun; W. S. Lee; M. H. Chang; J. Park; J. H. Kwon; D.-W. Kim;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Isolated molecular relapse in FIP1L1-PDGFRalpha hypereosinophilic syndrome after discontinuation and single weekly dose of imatinib: need of quantitative molecular procedures to modulate imatinib dose. [J] . Breccia M, Cilloni D, Cannella L, Cancer chemotherapy and pharmacology. . 2009,第6期

机译：伊马替尼停用和单周每周剂量后，FIP1L1-PDGFRalpha高嗜酸性粒细胞综合征的孤立分子复发：需要定量的分子程序来调节伊马替尼剂量。
2. Isolated molecular relapse in FIP1L1-PDGFRα hypereosinophilic syndrome after discontinuation and single weekly dose of imatinib: need of quantitative molecular procedures to modulate imatinib dose [J] . Massimo Breccia, Daniela Cilloni, Laura Cannella, Cancer Chemotherapy and Pharmacology . 2009,第6期

机译：伊马替尼停药和单周剂量后，FIP1L1-PDGFRα高嗜酸性综合征的孤立分子复发：需要定量的分子程序来调节伊马替尼剂量
3. Long-Term Follow-up after Treatment Discontinuation in Patients with Chronic Myeloid Leukemia: The Korean Imatinib Discontinuation (KID) Study [J] . Zang Dae Young, Lee Won Sik, Mun Yeung-Chul, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：治疗后的长期随访停止慢性骨髓白血病患者：韩国伊马替尼停止（儿童）研究
4. A bioinformatics pipeline for sequence to structure: A case study with a Cml patient undergoing treatment with imatinib [C] . Chacko Anita Rachel, Patil Shankarrao, Upadhayay Atul K., 2013 Biomedical Sciences and Engineering Conference . 2013

机译：用于构建序列的生物信息学流水线：以接受伊马替尼治疗的Cml患者为例
5. Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study [O] . Sung-Eun Lee, Soo Young Choi, Hye-Young Song, 2016

机译：KID研究表明伊马替尼戒断综合征和伊马替尼持续时间较长与停药后较低的分子复发密切相关
6. Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study [O] . Delphine Rea, Guylaine Henry, Zena Khaznadar, 2017

机译：自然杀手细胞计数与慢性骨髓白血病慢性骨髓性白血病中的伊马替尼停止后的分子复发存活相关：免疫研究
7. Indoor Carbon Dioxide Concentrations, VOCS, Environmental Sensitivity Association with Mucous Membrane and Lower Respiratory Sick Building Syndrome Symptoms in the Base Study: Analyses of the 100 Building Dataset [R] . Apte, M. G., Erdmann, C. A. 2002

机译：室内二氧化碳浓度，VOCs，环境敏感性与粘膜和下呼吸道病变建筑综合症的关联基础研究中的症状：100建筑数据集的分析

Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study

著录项

引文网络

相似文献

相关主题

期刊订阅